Purchase Short-Term Access

Outcome after Treatment of High-Risk Papillary and Non-Hurthle-Cell Follicular Thyroid Carcinoma
Terry Taylor, MD; Bonny Specker, PhD; Jacob Robbins, MD; Matthew Sperling; Mona Ho, MS; Kenneth Ain, MD; S. Thomas Bigos, MD; Jim Brierley, MB; David Cooper, MD; Bryan Haugen, MD; Ian Hay, MD; Vicki Hertzberg, PhD; Irwin Klein, MD; Herbert Klein, MD, PhD; Paul Ladenson, MD; Ronald Nishiyama, MD; Douglas Ross, MD; Steven Sherman, MD; Harry R. Maxon, MD
Annals of Internal Medicine 1998;129:622-627. doi:10.7326/0003-4819-129-8-199810150-00007

Purchase Online access to this article for 24 hours
Buy Now

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.